Emcure Pharmaceuticals Q4 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: -
BSE
1,491.05
7.45 (0.50%)
7.45 (0.50%)Volume8.43 K
Updated: Fri 18 Oct, 2024 | 15:29:58
NSE
1,493.6510.55 (0.71%)
10.55 (0.71%)Volume90.74 K
Updated: Fri 18 Oct, 2024 | 15:49:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | - | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6,658.25 | - | -% | 5,985.81 | -% |
| Selling/ General/ Admin Expenses Total | 1,913.31 | - | -% | 1,605.41 | -% |
| Depreciation/ Amortization | 312.41 | - | -% | 260.12 | -% |
| Other Operating Expenses Total | 919.76 | - | -% | 829.77 | -% |
| Total Operating Expense | 5,750.87 | - | -% | 5,070.56 | -% |
| Operating Income | 907.38 | - | -% | 915.25 | -% |
| Net Income Before Taxes | 727.23 | - | -% | 747.21 | -% |
| Net Income | 498.18 | - | -% | 532.02 | -% |
| Diluted Normalized EPS | 26.45 | - | -% | 28.39 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Hyundai IPO allotment status finalised: Latest GMP, how to check application status online, find direct links here
2 min read12:07 PM IST - Markets
02HDB Financial Services IPO: HDFC Bank arm to float ₹12,500-crore IPO; parent to offload ₹10k-crore shares via OFS
3 min read01:16 AM IST - Markets
03Hyundai IPO GMP crashes ahead of listing in the coming week. What does it mean?
2 min read03:52 PM IST